tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Adherium Limited Announces Cessation of Securities

Story Highlights
  • Adherium Limited operates in healthcare technology, focusing on respiratory medication adherence.
  • The company announced the cessation of over 418 million securities due to option expiry.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Adherium Limited Announces Cessation of Securities

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Adherium Ltd. ( (AU:ADR) ) has shared an announcement.

Adherium Limited announced the cessation of 418,539,981 securities due to the expiry of options without exercise or conversion as of June 30, 2025. This development may impact the company’s capital structure and could influence investor perceptions regarding its financial strategy and market positioning.

More about Adherium Ltd.

Adherium Limited operates in the healthcare technology industry, focusing on developing digital health solutions. The company primarily offers products and services related to respiratory medication adherence, providing tools and platforms to enhance patient outcomes and support healthcare providers.

Technical Sentiment Signal: Sell

Current Market Cap: A$8.98M

For a thorough assessment of ADR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1